Literature DB >> 22872205

Profile of ocular and systemic characteristics in Möbius sequence patients from Brazil and Italy.

Bruna Vieira Ventura1, Marilyn Tiller Miller, Diana Danda, Arturo Carta, Carlos Teixeira Brandt, Liana Oliveira Ventura.   

Abstract

PURPOSE: To compare the profiles and clinical findings of a series of patients with Möbius sequence from Brazil with a series from Italy.
METHODS: This is a multicenter study, which includes 46 Möbius sequence patients from Brazil and 20 from Italy. Socio-demographic, gestational, and neonatal profile characteristics were collected from interviews with the guardians of the Möbius sequence patients and compared. The Möbius sequence patients were submitted to an ophthalmologic examination and systemic malformations were also evaluated.
RESULTS: Misoprostol was used in the first trimester of pregnancy by 26 (56.5%) of the mothers of the Möbius sequence patients in the Brazilian series and was not used by any of the Italian mothers. The mean age of the Brazilian Möbius sequence patients was 89.95 ± 7.79 months and the mean age of the Italian patients was 102.6 ± 22.94 months (P=0.6105; Mann-Whitney test). Brazilian mothers had a significantly lower education level (P=0.0002; Fisher's exact test) and Italian mothers had significantly more stable relationships (p=0.0002; Fisher's exact test). The frequency of ocular and systemic abnormalities was similar in both series.
CONCLUSION: Adverse events during pregnancy varied between both groups. A history of misoprostol use during early pregnancy was present only in Brazilian mothers, who had lower levels of education and less frequent stable marital statuses. Clinical findings were similar between both groups of patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22872205     DOI: 10.1590/s0004-27492012000300011

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  6 in total

1.  Characterization of ocular motor deficits in congenital facial weakness: Moebius and related syndromes.

Authors:  Janet C Rucker; Bryn D Webb; Tamiesha Frempong; Harald Gaspar; Thomas P Naidich; Ethylin Wang Jabs
Journal:  Brain       Date:  2014-02-21       Impact factor: 13.501

2.  Diagnostic distinctions and genetic analysis of patients diagnosed with moebius syndrome.

Authors:  Sarah MacKinnon; Darren T Oystreck; Caroline Andrews; Wai-Man Chan; David G Hunter; Elizabeth C Engle
Journal:  Ophthalmology       Date:  2014-03-06       Impact factor: 12.079

3.  De novo mutations in PLXND1 and REV3L cause Möbius syndrome.

Authors:  Laura Tomas-Roca; Anastasia Tsaalbi-Shtylik; Jacob G Jansen; Manvendra K Singh; Jonathan A Epstein; Umut Altunoglu; Harriette Verzijl; Laura Soria; Ellen van Beusekom; Tony Roscioli; Zafar Iqbal; Christian Gilissen; Alexander Hoischen; Arjan P M de Brouwer; Corrie Erasmus; Dirk Schubert; Han Brunner; Antonio Pérez Aytés; Faustino Marin; Pilar Aroca; Hülya Kayserili; Arturo Carta; Niels de Wind; George W Padberg; Hans van Bokhoven
Journal:  Nat Commun       Date:  2015-06-12       Impact factor: 14.919

Review 4.  A framework for the evaluation of patients with congenital facial weakness.

Authors:  Bryn D Webb; Irini Manoli; Elizabeth C Engle; Ethylin W Jabs
Journal:  Orphanet J Rare Dis       Date:  2021-04-07       Impact factor: 4.123

5.  The epidemiology of Moebius syndrome in Italy.

Authors:  Arturo Carta; Stefania Favilla; Giacomo Calzetti; Maria Cristina Casalini; Pier Francesco Ferrari; Bernardo Bianchi; Maria Beatrice Simonelli; Roberta Farci; Stefano Gandolfi; Paolo Mora
Journal:  Orphanet J Rare Dis       Date:  2021-04-07       Impact factor: 4.123

6.  Moebius syndrome: clinical features, diagnosis, management and early intervention.

Authors:  Odoardo Picciolini; Matteo Porro; Elisa Cattaneo; Silvia Castelletti; Giuseppe Masera; Fabio Mosca; Maria Francesca Bedeschi
Journal:  Ital J Pediatr       Date:  2016-06-03       Impact factor: 2.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.